NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday that its second-quarter 2009 revenues declined 25 percent to $1.1 billion from $1.5 billion as its Electronic Measurement segment was hit particularly hard by the current economic downturn.

The Santa Clara, Calif.-based firm said that revenues for its Bio-Analytical Measurement segment were down 6 percent to $498 million from $530 million. Within that segment, its life science sales decreased 7 percent to $241 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.